Dan Brennan
Stock Analyst at TD Cowen
(4.24)
# 487
Out of 4,732 analysts
103
Total ratings
54.22%
Success rate
14.39%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WGS GeneDx Holdings | Maintains: Buy | $75 → $118 | $69.48 | +69.83% | 3 | Jan 7, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $86 | $51.74 | +66.22% | 6 | Nov 26, 2024 | |
| NTRA Natera | Maintains: Buy | $155 → $175 | $158.36 | +10.51% | 4 | Nov 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $250 | $163.50 | +52.91% | 5 | Nov 7, 2024 | |
| BRKR Bruker | Maintains: Hold | $72 → $70 | $56.88 | +23.07% | 1 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Buy | $166 → $177 | $136.67 | +29.51% | 12 | Nov 5, 2024 | |
| RVTY Revvity | Maintains: Buy | $141 → $144 | $118.39 | +21.63% | 3 | Nov 5, 2024 | |
| WAT Waters | Maintains: Hold | $363 → $410 | $404.00 | +1.49% | 3 | Nov 4, 2024 | |
| DHR Danaher | Maintains: Buy | $310 → $315 | $238.36 | +32.15% | 5 | Oct 23, 2024 | |
| A Agilent Technologies | Maintains: Buy | $153 → $160 | $147.36 | +8.58% | 12 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $42 | $36.66 | +14.57% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8.5 → $11 | $4.77 | +130.61% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $12.39 | +142.13% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $22.11 | +40.21% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $648 → $658 | $559.65 | +17.57% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $38.78 | +31.51% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $35.15 | +42.25% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2.8 | $1.15 | +143.48% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $20 | $14.21 | +40.75% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $15.08 | +112.20% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $373.70 | +46.11% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.96 | +257.14% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.64 | +814.63% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $198.11 | +17.11% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,295.43 | -32.07% | 3 | Oct 7, 2020 |
GeneDx Holdings
Jan 7, 2025
Maintains: Buy
Price Target: $75 → $118
Current: $69.48
Upside: +69.83%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $82 → $86
Current: $51.74
Upside: +66.22%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $158.36
Upside: +10.51%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $163.50
Upside: +52.91%
Bruker
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $56.88
Upside: +23.07%
Illumina
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $136.67
Upside: +29.51%
Revvity
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $118.39
Upside: +21.63%
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $404.00
Upside: +1.49%
Danaher
Oct 23, 2024
Maintains: Buy
Price Target: $310 → $315
Current: $238.36
Upside: +32.15%
Agilent Technologies
Aug 22, 2024
Maintains: Buy
Price Target: $153 → $160
Current: $147.36
Upside: +8.58%
Aug 8, 2024
Maintains: Buy
Price Target: $41 → $42
Current: $36.66
Upside: +14.57%
Aug 8, 2024
Maintains: Neutral
Price Target: $8.5 → $11
Current: $4.77
Upside: +130.61%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $12.39
Upside: +142.13%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $22.11
Upside: +40.21%
Jul 25, 2024
Maintains: Buy
Price Target: $648 → $658
Current: $559.65
Upside: +17.57%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $38.78
Upside: +31.51%
Jul 9, 2024
Initiates: Buy
Price Target: $50
Current: $35.15
Upside: +42.25%
May 13, 2024
Initiates: Buy
Price Target: $2.8
Current: $1.15
Upside: +143.48%
May 1, 2024
Maintains: Buy
Price Target: $21 → $20
Current: $14.21
Upside: +40.75%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $15.08
Upside: +112.20%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $373.70
Upside: +46.11%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $1.96
Upside: +257.14%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.64
Upside: +814.63%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $198.11
Upside: +17.11%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,295.43
Upside: -32.07%